Zobrazeno 1 - 10
of 83
pro vyhledávání: '"A 1 chieve study"'
Autor:
L Srinivasa Murthy, S Paramesh
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 557-560 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/5edb4195cb1448cdbf55e87179da113c
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 569-573 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/de2df6bdff6c4b0c9b29c670fa21166d
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 453-457 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/5f80e014377d49fa9815ed37c83ffa4b
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 472-476 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/d794c72841a7415d8ed39500424b1d5d
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 449-452 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/b9a84f0bdd864a0ea8c4122bde08308f
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 486-490 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/9becb0c846d34f8cb326b933601c5bc3
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 501-505 (2013)
Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care
Externí odkaz:
https://doaj.org/article/c5b8d49f24e042eea384eb39bb5a11ce
Autor:
Jothydev Kesavadev
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 565-568 (2013)
Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care
Externí odkaz:
https://doaj.org/article/979a0877fc2f48678bc7e32272dd0ccb
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 516-520 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/65aa66c7640b483f9d1b0afa9d1ba555
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 8, Pp 437-440 (2013)
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical ca
Externí odkaz:
https://doaj.org/article/e46167a15b0e425ca29749bf69ab13a8